Once again, the medtech industry has soared to new heights, eclipsing its all-time best performance by the tiniest of margins. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (July 2) at 114.59 points. It was just 0.01 points ahead of the 114.58-point mark set in […]
belluscura
Belluscura is back with an IPO in the U.K.
Belluscura last month filed for an initial public offering (IPO) more than three years after pulling its plans for going public in the U.K. The London-based company with U.S. headquarters in Plano, Texas, on May 24 confirmed an issue price of approximately $24.2 million (£17.5 million) for placing on the AIM market of the London […]
Belluscura pulls plans for $13m UK-based IPO
Medical device group Belluscura has reportedly pulled plans for a British initial public offering due to market condition issues, according to a report from the UK’s ProactiveInvestors. The announcement was reportedly made by backer Tekcapital, who said that the withdrawal was due to “current market conditions and certain other enterprise investment scheme/venture capital trust requirements having not […]
Belluscura plans IPO to commercialize licensed Stryker IP
Medical device group Belluscura is planning a U.K.-based IPO that could be worth up to $13.2 million after it picked up the rights to make and sell certain Stryker (NYSE:SYK) devices, according to a filing from the company. The company was created by Tekcapital in 2015 to pick up and commercialize rights to medical devices. So […]
